Table 1.

Demographic and medical history characteristics of study participants.

	Study Participants
	n=131
Age at Blood Draw, mean (SD), y	67.1 (9.7)
Years since FMP at Blood Draw, mean (SD), y	18.8 (10.8)†
White race/ethnicity, No. (%)	122 (93.1)
Education >High School, No. (%)	97 (74.1)†
BMI, mean (SD), kg/m2	29.9 (7.7)
Current Smoking, No. (%)	12 (9.2)
History of any CVD, No. (%)	11 (8.4)
Diabetes, No. (%)	18 (13.7)
Hypertensive, No. (%)	74 (56.5)
Systolic Blood Pressure, mean (SD), mmHg	132.3 (17.3)
Total cholesterol, mean (SD), mg/dL	208.4 (40.8)
Cancer in 2 years prior to Index Date, No. (%)	0 (0.0)
Hospitalization in 12 months prior to Index Date, No. (%)	4 (3.1)†
Inpatient Surgery in 12 months prior to Index Date, No (%)	3 (2.3)†
Hysterectomy/Oophorectomy, No. (%)
No Surgery	83 (63.4)
Hysterectomy-alone	20 (15.3)
Hysterectomy with BSO	22 (16.7)
Unknown	6 (94.6)
Ever estrogen HT use, No. (%)	88 (67.2)
Months Since Any HT Use at Blood Draw, mean (SD)	86.4 (67.5) n=96*

BMI=body mass index; BSO=bilateral salpingo oophorectomy; CVD=cardiovascular disease; FMP=final menstrual period; HT=hormone therapy; SD=standard deviation; y=year;

^*96 women used any HT (estrogen or progestogen) prior to blood draw.

^†Years since FMP n=101; Education n=129; Hospitalization n=128; Inpatient Surgery n=128